한글목차

세계 맞춤형 세포치료 시장은 2025년 175억 9,000만 달러, 2032년에는 820억 8,000만 달러에 달할 것으로 예측되며, 2025-2032년 연평균 24.6%의 성장률을 보일 것으로 예상됩니다.

그림. 2025년 지역별 맞춤형 세포치료 시장 점유율(%)

세계 맞춤형 세포치료 시장의 성장을 주도하는 것은 다양한 만성질환 및 생명을 위협하는 질병을 치료하기 위한 첨단 세포치료를 개발하기 위한 주요 기업들의 연구개발 투자 증가입니다. 맞춤형 세포치료는 환자 자신의 몸에서 세포를 분리하고 조작하여 치료 효과를 창출하는 것을 포함합니다. 이 새로운 부문은 암, 신경질환, 심혈관질환 등의 치료제 개발에 유망한 분야입니다. 유전체학, 세포생물학, 공학 기술의 발전으로 과학자들은 건강한 상태와 질병 상태에서 세포가 어떻게 기능하는지에 대해 더 잘 이해하고 있습니다. 더 많은 세포 치료 제품이 규제 당국의 승인을 받고 임상 현장에서 채택됨에 따라 시장은 성장할 수 있습니다.

시장 역학

세계 맞춤형 세포치료 시장의 성장은 암 및 기타 난치성 질환의 유병률 증가, 만성질환에 취약한 노인 인구 증가, 재생의료의 채택 확대, 세포치료의 적용 확대, 생명공학의 발전, 세포 기반 연구에 대한 막대한 투자 등 여러 가지 요인에 의해 주도되고 있습니다. 그러나 높은 치료 비용, 긴 개발 주기, 임상시험을 둘러싼 규제 장벽은 시장 성장에 걸림돌이 될 수 있으며, iPSC(인공만능줄기세포) 기술의 지속적인 연구, CAR T 세포 치료의 채택, 동종 세포 치료의 연구 개발, 세포 치료의 효과에 대한 증거 축적은 이해관계자들에게 유리한 기회를 제공할 수 있습니다. 이해관계자들에게 유리한 기회를 제공할 수 있습니다.

본 조사의 주요 특징

• 세계의 맞춤형 세포치료 시장을 상세하게 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모(10억 달러)와 연평균 성장률(CAGR)에 대해 조사 분석하여 전해드립니다.
• 또한, 다양한 부문에 걸친 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
• 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 맞춤형 세포 치료 시장의 주요 기업을 프로파일링합니다.
• 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것으로 보입니다.
• 세계 맞춤형 세포치료 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 세계 맞춤형 세포치료 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.

목차

제1장 조사 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map (COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
• 영향 분석
• 시장 동향
• 규제 시나리오
• 인수와 제휴 시나리오
• 자금조달과 투자
• PEST 분석
• Porter의 Five Forces 분석

제4장 세계의 맞춤형 세포치료 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

• 전체적인 영향
• 정부 이니셔티브
• 시장에 대한 COVID-19의 영향

제5장 세계의 맞춤형 세포치료 시장, 세포 유형별, 2020-2032년(10억 달러)

• 서론
• 림프구
• 중간엽 줄기세포
• 조혈모세포
• 기타

제6장 세계의 맞춤형 세포치료 시장, 치료 영역별, 2020-2032년(10억 달러)

• 서론
• 심혈관 질환
• 신경 질환
• 염증성 질환
• 당뇨병
• 암

제7장 세계의 맞춤형 세포치료 시장, 최종사용자별, 2020-2032년(10억 달러)

• 서론
• 병원
• 재택치료
• 전문 클리닉
• 기타

제8장 세계의 맞춤형 세포치료 시장, 지역별, 2020-2032년(10억 달러)

• 서론
• 북미
• 라틴아메리카
• 유럽
• 아시아태평양
• 중동
• 아프리카

제9장 경쟁 구도

• 기업 개요
  • Thermo Fisher Scientific, Inc.
  • Novartis AG
  • Gilead Sciences, Inc.
  • Pfizer Inc.
  • Amgen Inc.
  • Bluebird Bio, Inc.
  • Personalis, Inc.
  • Adaptimmune Therapeutics PLC
  • BioNTech SE
  • Sangamo Therapeutics, Inc.
  • Regeneron Pharmaceuticals, Inc.
  • CRISPR Therapeutics AG
  • Caribou Biosciences, Inc.
  • Mustang Bio, Inc.
  • Fate Therapeutics, Inc.
  • Atara BIoTherapeutics, Inc.
  • Holostem Terapie Avanzate Srl
• 융성과 쇠퇴
• Coherent Opportunity Map

제10장 참고 문헌과 조사 방법

• 참고 문헌
• 조사 방법

영문목차

Global Personalized Cell Therapy Market is estimated to be valued at USD 17.59 Bn in 2025 and is expected to reach USD 82.08 Bn by 2032, growing at a compound annual growth rate (CAGR) of 24.6% from 2025 to 2032.

Figure. Personalized Cell Therapy Market Share (%), By Region 2025

Global personalized cell therapy market growth is driven by increasing R&D investments by key players in developing advanced cell therapies for treating various chronic and life-threatening diseases. Personalized cell therapy involves isolation and manipulation of cells from patient's own body to produce therapeutic effects. This emerging field holds promise for developing curative treatments for cancer, neurological disorders, cardiovascular diseases and others. With advancements in genomics, cell biology and engineering technologies, scientists are gaining deeper understanding of how cells function in healthy and diseased conditions, thus, allowing them to exploit cells' therapeutic potential in a personalized way. The market can witness growth as more cell therapy products receive regulatory approvals and get adopted in clinical practice.

Market Dynamics:

Global personalized cell therapy market growth is driven by several factors such as rising prevalence of cancer and other incurable diseases, growing geriatric population susceptible to chronic illnesses, increasing adoption of regenerative medicines, expanding applications of cell therapies, advances in biotechnology, and heavy investments in cell-based research. However, high treatment costs, long development cycles, and regulatory hurdles surrounding clinical trials can hamper the market growth. Ongoing research on iPSC (induced pluripotent stem cells) technology, adoption of CAR T-cell therapies, development of allogenic cell therapies, growing body of evidence on effectiveness of cell therapies can offer lucrative opportunities for stakeholders.

Key Features of the Study:

• This report provides in-depth analysis of the global personalized cell therapy market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global personalized cell therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Juno Therapeutics, Cellectis, Bellicum Pharmaceuticals, Vericel, Pharmicell, Pluristem Therapeutics, BioLineRx, Mesoblast.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global personalized cell therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global personalized cell therapy market.

Detailed Segmentation-

• By Cell Type
  • Lymphocytes
  • Mesenchymal Stem Cell
  • Hematopoietic Stem Cell
  • Others
• By Therapeutic Area
  • Cardiovascular Diseases
  • Neurological Disorders
  • Inflammatory Diseases
  • Diabetes
• By End Users
  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Thermo Fisher Scientific, Inc.
  • Novartis AG
  • Gilead Sciences, Inc.
  • Pfizer Inc.
  • Amgen Inc.
  • Bluebird Bio, Inc.
  • Personalis, Inc.
  • Adaptimmune Therapeutics PLC
  • BioNTech SE
  • Sangamo Therapeutics, Inc.
  • Regeneron Pharmaceuticals, Inc.
  • CRISPR Therapeutics AG
  • Caribou Biosciences, Inc.
  • Mustang Bio, Inc.
  • Fate Therapeutics, Inc.
  • Atara Biotherapeutics, Inc.
  • Holostem Terapie Avanzate S.r.l

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Cell Type
  • Market Snapshot, By Therapeutic Area
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Personalized Cell Therapy Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Personalized Cell Therapy Market, By Cell Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Lymphocytes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Mesenchymal Stem Cell
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Hematopoietic Stem Cell
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Personalized Cell Therapy Market, By Therapeutic Area, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Cardiovascular Diseases
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Neurological Disorders
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Inflammatory Diseases
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Diabetes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Personalized Cell Therapy Market, By End Users, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Hospitals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Homecare
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Specialty Clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Personalized Cell Therapy Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • U.S.
  • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

• Company Profiles
  • Thermo Fisher Scientific, Inc.
  • Company Highlights
  • Therapeutic Area Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Novartis AG
  • Company Highlights
  • Therapeutic Area Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Gilead Sciences, Inc.
  • Company Highlights
  • Therapeutic Area Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Pfizer Inc.
  • Amgen Inc.
  • Bluebird Bio, Inc.
  • Personalis, Inc.
  • Adaptimmune Therapeutics PLC
  • BioNTech SE
  • Sangamo Therapeutics, Inc.
  • Regeneron Pharmaceuticals, Inc.
  • CRISPR Therapeutics AG
  • Caribou Biosciences, Inc.
  • Mustang Bio, Inc.
  • Fate Therapeutics, Inc.
  • Atara Biotherapeutics, Inc.
  • Holostem Terapie Avanzate S.r.l
• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact

"